The agency noted, however, that the drug didnt necessarily cause those cases.
The label explains that Ozempic causes a delay of gastric emptying, which may lead to gastrointestinal reactions.
The labels for those medications say they delay gastric emptying, which can cause various gastrointestinal problems.
Bloomberg / Getty Images
However, they dont mention stomach paralysis and stomach inflammation.
U.S. Food and Drug Administration.Drug safety-related label changes.
U.S. Food and Drug Administration.OZEMPIC (semaglutide) injection, for subcutaneous use Initial U.S. Approval: 2017.
Chamberlin S, Dabbs W.Semaglutide (Ozempic) for key in 2 Diabetes Mellitus.Am Fam Physician.
2019;100(2):116-117.
